<SEC-DOCUMENT>0001104659-21-152461-index.html : 20211222
<SEC-HEADER>0001104659-21-152461.hdr.sgml : 20211222
<ACCEPTANCE-DATETIME>20211222092022
ACCESSION NUMBER:		0001104659-21-152461
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20211222
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20211222
DATE AS OF CHANGE:		20211222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		211511213

	BUSINESS ADDRESS:	
		STREET 1:		25-28 NORTH WALL QUAY
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			D01 H104
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		414 COMMERCE DRIVE
		STREET 2:		STE 120
		CITY:			FORT WASHINGTON
		STATE:			PA
		ZIP:			19034

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2136101d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: tm2136101d1_8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>2 <FILENAME>nbrv-20211222.xsd <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA <TEXT> Document 2 - file: nbrv-20211222.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>3 <FILENAME>nbrv-20211222_lab.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE <TEXT> Document 3 - file: nbrv-20211222_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>4 <FILENAME>nbrv-20211222_pre.xml <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE <TEXT> Document 4 - file: nbrv-20211222_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>5 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 5 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>6 <FILENAME>tm2136101d1_8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 6 - file: tm2136101d1_8k_htm.html
Document 6 - RAW XML: tm2136101d1_8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>7 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 7 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>8 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 8 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: FilingSummary.html
Document 10 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>13 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>14 <FILENAME>0001104659-21-152461-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: 0001104659-21-152461-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>